Ruan X - Search Results

1

Persistent pre-exhausted CD8+ T cells shape the tumor immune microenvironment in anaplastic thyroid cancer.

Ruan X, Tao M, Dong Y, Hu L, Xu G, Hu C, Huang Y, Wang Y, Yu J, Luo W, Gao M, Zhao M, Zheng X. Ruan X, et al. Endocr Relat Cancer. 2025 Jan 1:ERC-24-0169. doi: 10.1530/ERC-24-0169. Online ahead of print. Endocr Relat Cancer. 2025. PMID: 39752183

2

Antitumor effects of anlotinib in thyroid cancer.

Ruan X, Shi X, Dong Q, Yu Y, Hou X, Song X, Wei X, Chen L, Gao M. Ruan X, et al. Endocr Relat Cancer. 2019 Jan 1;26(1):153-164. doi: 10.1530/ERC-17-0558. Endocr Relat Cancer. 2019. PMID: 30139768 Free PMC article.

3

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients.

Wu Y, Wang H, Zhi J, Hu L, Hou X, Ruan X, Zheng X, Liu H, Gao M. Wu Y, et al. Among authors: ruan x. Onco Targets Ther. 2019 Aug 28;12:6937-6945. doi: 10.2147/OTT.S219506. eCollection 2019. Onco Targets Ther. 2019. PMID: 31695409 Free PMC article.

4

Genome-wide identification of m6A-associated functional SNPs as potential functional variants for thyroid cancer.

Ruan X, Tian M, Kang N, Ma W, Zeng Y, Zhuang G, Zhang W, Xu G, Hu L, Hou X, Xie W, Gao M, Piao Y, Guo S, Zheng X. Ruan X, et al. Am J Cancer Res. 2021 Nov 15;11(11):5402-5414. eCollection 2021. Am J Cancer Res. 2021. PMID: 34873468 Free PMC article.

5

Reduced MHC class II expression in medullary thyroid cancer identifies patients with poor prognosis.

Ruan X, Yi J, Hu L, Zhi J, Zeng Y, Hou X, Huang J, Gu P, Hao W, Gao M, Pan Y, Wei S, Zheng X. Ruan X, et al. Endocr Relat Cancer. 2022 Jan 20;29(2):87-98. doi: 10.1530/ERC-21-0153. Endocr Relat Cancer. 2022. PMID: 34874277

6

Dysregulation of miR-551b-5p and SETD2 Predicts Poor Prognosis and Promotes Migration and Invasion of Thyroid Cancers.

Dong A, Gao M, Zheng X, Ruan X. Dong A, et al. Among authors: ruan x. Endocr Metab Immune Disord Drug Targets. 2023;23(11):1400-1409. doi: 10.2174/1871530323666230417083509. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37073141

7

Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer.

Ma W, Tian M, Hu L, Ruan X, Zhang W, Zheng X, Gao M. Ma W, et al. Among authors: ruan x. J Cancer. 2023 May 29;14(9):1592-1604. doi: 10.7150/jca.83853. eCollection 2023. J Cancer. 2023. PMID: 37325052 Free PMC article.

8

Consistent analysis of differentially expressed genes across 7 cell types in papillary thyroid carcinoma.

Ruan X, Huang Y, Geng L, Tian M, Liu Y, Tao M, Zheng X, Li P, Zhao M. Ruan X, et al. Comput Struct Biotechnol J. 2023 Oct 27;21:5337-5349. doi: 10.1016/j.csbj.2023.10.045. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 37954148 Free PMC article.

9

High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion.

Zhao J, Yun X, Ruan X, Chi J, Yu Y, Li Y, Zheng X, Gao M. Zhao J, et al. Among authors: ruan x. Onco Targets Ther. 2019 Feb 18;12:1309-1318. doi: 10.2147/OTT.S184560. eCollection 2019. Onco Targets Ther. 2019. PMID: 30863097 Free PMC article.

10

Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.

Zhang J, Sun B, Ruan X, Hou X, Zhi J, Meng X, Zheng X, Gao M. Zhang J, et al. Among authors: ruan x. Cancer Biol Med. 2021 Feb 15;18(1):105-119. doi: 10.20892/j.issn.2095-3941.2020.0098. Cancer Biol Med. 2021. PMID: 33628588 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,341 results

Search Page

Filters